Education
About Us
Working with TipRanks
Follow Us
VNGLF - ETF AI Analysis
Top Page
Vanguard FTSE Developed Europe UCITS ETF Accum EUR (VNGLF)
Rating:64Neutral
Price Target:―
Positive Factors
Broad European Diversification
The fund spreads its investments across many developed European countries, which helps reduce the impact of problems in any single market.
Low Expense Ratio
The ETF charges a very low ongoing fee, so more of the fund’s returns stay in investors’ pockets over time.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating generally supportive market conditions for its holdings.
Negative Factors
Heavy Tilt to Financials and Industrials
A large share of the portfolio is in financial and industrial companies, which can hurt returns if these sectors face a downturn.
Mixed Performance Among Top Holdings
While some major positions have performed strongly, several other large holdings have been weak this year, which can drag on overall results.
Limited Exposure Beyond Developed Europe
The ETF is focused mainly on developed European markets with only a small allocation to the U.S., offering little exposure to faster-growing regions elsewhere.
VNGLF vs. SPDR S&P 500 ETF (SPY)
AUM2.33B
RegionEurope
Expense Ratio0.10%
Beta0.64
IssuerVanguard
Inception DateJul 23, 2019
Dividend YieldN/A
Asset ClassEquity
Index TrackedFTSE Developed Europe Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume17,143
30 Day Avg. Volume27,174
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
73.57Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering499
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VNGLF Summary
This ETF, the Vanguard FTSE Developed Europe UCITS ETF, aims to track the FTSE Developed Europe Index, which covers many major companies across developed European countries like the UK, France, and Germany. It holds well-known names such as Nestlé, Shell, and AstraZeneca, and spreads your money across many sectors including financials, industrials, and health care. Someone might invest in this fund to get broad, low-cost diversification in European stocks and to benefit from reinvested dividends for long-term growth. A key risk is that its value can rise and fall with the European stock market.
How much will it cost me?The Vanguard FTSE Developed Europe UCITS ETF (VNGLF) has an expense ratio of 0.1%, meaning you’ll pay $1 per year for every $1,000 invested. This is lower than average because the fund is passively managed, tracking the FTSE Developed Europe Index to keep costs down.
What would affect this ETF?Positive drivers for VNGLF include potential economic growth in developed European countries like Germany, France, and the UK, which could boost the performance of its top holdings in sectors such as financials, healthcare, and technology. However, negative factors such as rising interest rates or geopolitical tensions in Europe could impact market stability and weigh on the ETF's performance. Additionally, sector-specific challenges, like regulatory changes in healthcare or energy, could affect the fund's returns.
VNGLF Top 10 Holdings
This Europe-focused Vanguard fund leans heavily on a mix of health care, financials, and industrials, with all its big names based in developed European markets. ASML is one of the main engines, rising steadily and giving the fund a tech-powered boost. Roche, Novartis, and HSBC are also pulling their weight, keeping the core of the portfolio in good shape. On the flip side, SAP and LVMH have been losing steam lately, while Nestlé looks soft, slightly dragging on what is otherwise a broadly diversified European lineup.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.03% | $190.53M | €475.49B | 74.46% | 76 Outperform | |
| Roche Holding AG | 2.07% | $130.32M | CHF294.84B | 46.01% | 73 Outperform | |
| AstraZeneca | 1.97% | $124.35M | $323.92B | 30.42% | 80 Outperform | |
| HSBC Holdings | 1.93% | $121.26M | £222.90B | 45.63% | 80 Outperform | |
| Novartis AG | 1.89% | $118.79M | CHF242.43B | 28.84% | 80 Outperform | |
| SAP SE | 1.79% | $112.54M | €197.41B | -36.18% | 66 Neutral | |
| Nestlé SA | 1.79% | $112.47M | CHF198.29B | 10.92% | 71 Outperform | |
| Shell (UK) | 1.51% | $95.33M | £165.51B | 11.49% | 73 Outperform | |
| Siemens | 1.47% | $92.26M | €191.01B | 9.25% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.37% | $86.43M | €265.40B | -20.87% | 78 Outperform |
VNGLF Technical Analysis
Positive
―
Price Trends
64.73
Positive
62.48
Positive
59.92
Positive
Market Momentum
0.82
Positive
65.31
Neutral
80.75
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VNGLF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.72, equal to the 50-day MA of 64.73, and equal to the 200-day MA of 59.92, indicating a bullish trend. The MACD of 0.82 indicates Positive momentum. The RSI at 65.31 is Neutral, neither overbought nor oversold. The STOCH value of 80.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VNGLF.
VNGLF Peer Comparison
Comparison Results
Performance Comparison
VNGLF
Vanguard FTSE Developed Europe UCITS ETF Accum EUR
67.73
16.59
32.44%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents